240 related articles for article (PubMed ID: 22664110)
1. Prognostic significance of HOXB4 in de novo acute myeloid leukemia.
Umeda S; Yamamoto K; Murayama T; Hidaka M; Kurata M; Ohshima T; Suzuki S; Sugawara E; Kawano F; Kitagawa M
Hematology; 2012 May; 17(3):125-31. PubMed ID: 22664110
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of leukemia stem/progenitor cell related gene expression in acute leukemia].
Zhu HB; Zhao MF; Xie F; Xiao X; Xu XN; Mu J; Yang JW; Liu PJ; Lü HR; Li YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1150-5. PubMed ID: 22040961
[TBL] [Abstract][Full Text] [Related]
3. [Expression of HOXB4, PRDM16 and HOXA9 in Patients with Acute Myeloid Leukemia and Its Clinical Significance].
Li L; Zhao CT; Cui BL; Wu SL; Liu XD; Su Z; Yang J; Wang W; Cui ZG; Zhao HG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):326-31. PubMed ID: 27150986
[TBL] [Abstract][Full Text] [Related]
4. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.
Yu H; Neale G; Zhang H; Lee HM; Ma Z; Zhou S; Forget BG; Sorrentino BP
Blood; 2014 Sep; 124(11):1737-47. PubMed ID: 25082879
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of HHEX in Acute Myeloid Leukemia with t(8;21)(q22;q22) Translocation.
Zhang S; Ma L; Chen Y; Xu H; Chen S; Wu W
Ann Clin Lab Sci; 2017 Nov; 47(6):687-697. PubMed ID: 29263042
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation.
Unger C; Kärner E; Treschow A; Stellan B; Felldin U; Concha H; Wendel M; Hovatta O; Aints A; Ahrlund-Richter L; Dilber MS
Stem Cells; 2008 Oct; 26(10):2455-66. PubMed ID: 18617691
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
9. Hoxb4-YFP reporter mouse model: a novel tool for tracking HSC development and studying the role of Hoxb4 in hematopoiesis.
Hills D; Gribi R; Ure J; Buza-Vidas N; Luc S; Jacobsen SE; Medvinsky A
Blood; 2011 Mar; 117(13):3521-8. PubMed ID: 21278354
[TBL] [Abstract][Full Text] [Related]
10. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.
Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF
Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634
[TBL] [Abstract][Full Text] [Related]
11. Molecular integration of HoxB4 and STAT3 for self-renewal of hematopoietic stem cells: a model of molecular convergence for stemness.
Hong SH; Yang SJ; Kim TM; Shim JS; Lee HS; Lee GY; Park BB; Nam SW; Ryoo ZY; Oh IH
Stem Cells; 2014 May; 32(5):1313-22. PubMed ID: 24446131
[TBL] [Abstract][Full Text] [Related]
12. Low SOX17 expression: prognostic significance in de novo acute myeloid leukemia with normal cytogenetics.
Tang CY; Lin J; Qian W; Yang J; Ma JC; Deng ZQ; Yang L; An C; Wen XM; Zhang YY; Qian J
Clin Chem Lab Med; 2014 Dec; 52(12):1843-50. PubMed ID: 24955525
[TBL] [Abstract][Full Text] [Related]
13. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
Zhou JD; Zhang TJ; Wang YX; Yang DQ; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
15. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
16. BP1 overexpression is associated with adverse prognosis in de novo acute myeloid leukemia.
Zhou JD; Yang J; Guo H; Deng ZQ; Wen XM; Yang L; Yin JY; Xiao GF; Lin J; Qian J
Leuk Lymphoma; 2016; 57(4):828-34. PubMed ID: 26325005
[TBL] [Abstract][Full Text] [Related]
17. [Expression of BCL2L12 gene in de novo acute myeloid leukemia and its clinical implications].
Yu MX; Lu Y; Mu QT; Wang Q; Chen ZM; Lou JY; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):544-8. PubMed ID: 24078567
[TBL] [Abstract][Full Text] [Related]
18. [Expression of antiapoptotic gene aven in de novo acute myeloid leukemia patients and its clinical significance].
Geng SX; DU X; Weng JY; Zhong LY; Guo R; Lu ZS; Chen ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1424-8. PubMed ID: 20030919
[TBL] [Abstract][Full Text] [Related]
19. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
[TBL] [Abstract][Full Text] [Related]
20. Effect of human cytomegalovirus infection on the expression of Hoxb2 and Hoxb4 genes in the developmental process of cord blood erythroid progenitors.
Liu WJ; Huang MX; Guo QL; Chen JH; Shi H
Mol Med Rep; 2011; 4(6):1307-11. PubMed ID: 21879259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
